Syed Mazher

Senior Research Scientist

Dr. Syed Mazher is a distinguished Molecular Biologist, Biochemist, and Virologist with a career spanning 28 years. He earned his Bachelor of Science (B.Sc.) degree in Botany, Zoology, and Chemistry from Osmania University, Hyderabad, India, in 1985. In 1988, he completed his Master of Science (M.Sc.) in Biochemistry at Osmania University. Dr. Hussain continued his academic journey and earned his Doctor of Philosophy (Ph.D.) in Biochemistry from Osmania University in 1995. In 2003, he further expanded his expertise by completing a Postdoctoral Fellowship in Viral Oncogenesis and Tumor Immunology at St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. With a strong foundation in molecular biology and virology, Dr. Hussain has made significant contributions to the fields of immunology, cancer biology, and molecular diagnostics. His early work focused on identifying mutations associated with severe hemoglobinopathies and establishing diagnostic laboratories in India, contributing to the development of prenatal diagnostic services for these conditions in the region.

Dr. Mazher’s impact extends beyond the laboratory. He has been actively involved in teaching, mentoring, and community service. Dr. Hussain has supervised and trained MD students, PhD students, Clinical Fellows, Postdoctoral Fellows, and laboratory staff, playing key roles in project management and regulatory compliance. His extensive list of publications and active participation in academic and community activities underscore his dedication to advancing scientific knowledge and research, establishing him as a prominent figure in the life and health sciences.
Dr. Mazher’s research interests at ADSCC include the development of in vitro models to study the molecular aspects of epithelial to mesenchymal transition (EMT) in the context of the tumor microenvironment (TME), the development of immunotherapeutic protocols for cancer, and the establishment of various animal models for understanding the pathogenesis of hepatitis C virus (HCV) infection, studying the molecular mechanisms of graft versus host disease (GvHD) due to stem cell or bone marrow transplantation (SCT, BMT), evaluating the efficacies of cancer vaccines against aggressive human cancers, and establishing stem cell-based protocols for the treatment of diabetes.